F030 Practice Management: Teledermatology Session
DESCRIPTION
This session will explore the evolving landscape of virtual care delivery in dermatology, teaching participants key skills and best practices for leveraging innovative telemedicine modalities and platforms to optimize access to care, facilitate triage decisions, improve patient outcomes, and support health equity. Participants will learn about the various modes of virtual care, including live-interactive visits, online digital evaluation and management, interprofessional e-consults, inbox management and telepathology. Presenters will demonstrate how virtual care can be effectively implemented to expand practice reach and increase access to dermatologist-level care across wide-ranging practice models.
LEARNING OBJECTIVES
Explain various modes of virtual care delivery (e.g., live-interactive, store-and-forward, e-consults, inbox management, telepathology) and review their optimal use in the practice of dermatology.
Discuss and examine evidence for new teledermatology tools and virtual practice models to increase access to care, improve patient outcomes, optimize in-person care, and support health equity.
Demonstrate efficient and effective virtual care models and workflows applicable in a variety of dermatology practice models.
DIRECTOR
Veena Vanchinathan, MD, FAAD
SPEAKERS
Lia Gracey Maniar, MD, PhD, FAAD
Jules Lipoff, MD, FAAD
Sara Harcharik Perkins, MD, FAAD
Melanie Jane Tuerk, MD, FAAD
Kaiser Permanente
DISCLOSURES
Lia Gracey Maniar, MD, PhD, FAAD
No financial relationships exist with ineligible companies.
Jules Lipoff, MD, FAAD
Amgen – Consultant (1099 relationship)(Fees); Guidepoint Global, LLC – Consultant(Fees); Pfizer Inc. – Investigator(Grants/Research Funding); Springer Science & Business Media – Other(Patent royalties or other compensation for Intellectual Property Rights); Takeda Pharmaceuticals USA Inc – Advisory Board(Fees); UpToDate – Other(Other Financial Benefit);
Sara Harcharik Perkins, MD, FAAD
Hims – Advisory Board(Fees);
Melanie Jane Tuerk, MD, FAAD
No financial relationships exist with ineligible companies.
Veena Vanchinathan, MD, FAAD
No financial relationships exist with ineligible companies.